Ym477 License Agreement Sample Contracts

EX-10.4 8 a2232291zex-10_4.htm EX-10.4 ***Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4) and 230.406 YM477 LICENSE AGREEMENT

Ym477 License Agreement • May 5th, 2020 • New York

• Contract Type
  Ym477 License Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

This Agreement is made as of August 15, 2005, by and between Astellas Pharma Inc., a company organized and existing under the laws of Japan and having its principal office at 3·11, Nihonbasbi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411, Japan (“Licensor”) and AkaRx Corp., a company organized and existing under the laws of Delaware and having its principal office at Mack Centre IV, 4th Floor, 61 S. Paramus Road, Paramus, NJ 07652 (“Licensee”).